$BCRX News Article - INESSS Recommends Public Reimbursement for BioCryst's ORLADEYO (berotralstat) for the Prevention of Attacks for Hereditary Angioedema Patients in Qu bec https://marketwirenews.com/news-releases/ines...40066.html
(0)
(0)
BioCryst Pharmaceuticals Inc. (BCRX) Stock Research Links